{"id":973255,"date":"2026-06-17T11:00:52","date_gmt":"2026-06-17T15:00:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/"},"modified":"2026-06-17T11:00:52","modified_gmt":"2026-06-17T15:00:52","slug":"aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/","title":{"rendered":"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">ESTERO, Fla., June  17, 2026  (GLOBE NEWSWIRE) &#8212; Aspire Biopharma Holdings, Inc.\u2019s (Nasdaq: ASBP) (\u201cAspire\u201d or the \u201cCompany\u201d), today announced that it will present live at the Life Sciences Investor Forum hosted by <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aOq0-05G6ffi_uAfR7taQEMxbCb8LTOQEvPZpbnJ9vRGhzpV6KCmY-YKdpTA54Dx6xUyJBtyo8V8BuuzhP7e-hQ9of8Um5etLxp1i_ut_xpPWKtyj2NIAaVMGl8dbYFrwKI30jGBkXepJ8mRgYRpMg==\" rel=\"nofollow\" target=\"_blank\">VirtualInvestorConferences.com<\/a> on June 25<sup>th<\/sup>, 2026.<\/p>\n<p>\n        <strong>DATE<\/strong>: June 25<sup>th<\/sup>\u00a0\u00a0<\/p>\n<p>\n        <strong>TIME: 2:00 pm ET<\/strong>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MP6UiOfiuwZJHW3cppamZqDX9VFbq4L2HpKiVQbn-e1jJVw9EmU_uw8vu6cgfMz8rEKLgFz-H7pnyFseA3Uwx6-sKf7weYg-v_TlJtTWoIHaRu6GIfEm4nO_-o--eb0UZtO87H5dtYKtkE-hz9osxrwyrPE_MjeDZ3L9G1w7sMjFQw_JkvnN7tVUlvoq721uzNjuNRQ7mNtMIL4BZXUtc-iAe_MVwspQZ_YWyEsv4q1Lfn2GYYtUfcqBzlZgVjnI4AormWaOLGTcX93oNqfc8kRUlfwnvfgcu7XhWBE_ArY=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>REGISTER HERE<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>Available for 1&#215;1 meetings: June 24-25. Schedule 1&#215;1 Meetings <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nHUz2tPw7N5c9ttVmjcSrwB99xNtl6jjKWL25SQYKOsSe3lTZJ0NvL-FTLxbNMB92B6-JXayzSg4VTMGL8vdg8_nFUCNpx-4xENgP6qGOkRNV6zRd_uS95HlARfm4Gm_x5vibMnmTVQDBKcYyJQWdTrUh7r7TWutl_P1cnbZjqobQ1GSgrNqTz5sZt644V7gFSEQN-6Hn5UnqiN15wrlaA==\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference.<\/p>\n<p>It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.<\/p>\n<p>Learn more about the event at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XCVrg3imK03L639E2ZofsT9ZWLnKFCCBa_zNF_iqbw8wHqnPMAjlKPXpTml14Rvtj2oEU2fbefaYhe6s8Fo5aepwxC77Uzo785n6G51oF0mlnRgJ1wu2ZT7VHOJoNrDCMElTf6nwLL4pvhOodj7G6A==\" rel=\"nofollow\" target=\"_blank\"><u>www.virtualinvestorconferences.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Company Highlights<\/strong>\n      <\/p>\n<p>Multiple \u211e applications in heart attack\/stroke, anti-anxiety, antiplatelet, nausea and others<\/p>\n<p>Large Addressable Markets for \u211e and Supplements<\/p>\n<p>Focused on commercialization through partnerships, licensing and internal development\u00a0<\/p>\n<p>Omnibus patent and four provisional patents filed for approved therapeutics in multi-billion-dollar markets<\/p>\n<p>Lead Drug Candidate High Dose Aspirin Prescription Product: Trial demonstrated dramatically higher and more rapid therapeutic impact compared to standard chewed aspirin tablets, safe and well-tolerated which is critical during suspected heart attacks, when clots blocking heart arteries can cause permanent muscle damage.<\/p>\n<p>BUZZ BOMB<sup>\u2122<\/sup>, New Caffeine Product: Commercial revenue in 2025 with new e-commerce website, packaging and product launched January 2026<\/p>\n<p>Proposed acquisition of Dura Driver Control Systems, a leading global automotive supplier with a 100+ year history and $200M+ in 2025 revenue expected to close Q3 (unaudited)<\/p>\n<p>\n        <strong>About Virtual Investor Conferences<sup>\u00ae<\/sup><\/strong>\n      <\/p>\n<p>Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.<\/p>\n<p>\n        <strong>About Aspire Biopharma Holdings, Inc.<\/strong>\n      <\/p>\n<p>Aspire Biopharma delivers supplements to the body rapidly and precisely.<br \/>For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JHse1n2UkHR1z6HDwkHGjSPq8LwjDTvtvilD9ytUWP4dl3DMhKSUymdoWr4jhhf9AiAyi3qLUsSwXrb2UKJfk2CAkD2rkNHIKuUMTXAKCuo=\" rel=\"nofollow\" target=\"_blank\">www.aspirebiolabs.com<\/a>.<\/p>\n<p>\n        <strong>Aspire Biopharma Holdings, Inc.<\/strong><br \/>\n        <br \/>\n        <strong>Contact<\/strong>\n      <\/p>\n<p>PCG Advisory<br \/>Kevin McGrath<br \/>+1-646-418-7002<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=exGRedVBPraOUe0ZqvcCDKzJ4AoqFmZMmE_7a66N-WSIz6yVZOrlDScxLuesutSCzWt1j_Dxm8fVW0S8ecl8o_WWX0PZkiyb8Q-FlgAOZOM=\" rel=\"nofollow\" target=\"_blank\">kevin@pcgadvisory.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OGUxYTg1MjQtNjA2Ny00NWFlLThmNzAtODYwZjJmNTBkNzNlLTEyNDQ1OTQtMjAyNi0wNi0xNy1lbg==\/tiny\/Virtual-Investor-Conferences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) &#8212; Aspire Biopharma Holdings, Inc.\u2019s (Nasdaq: ASBP) (\u201cAspire\u201d or the \u201cCompany\u201d), today announced that it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25th, 2026. DATE: June 25th\u00a0\u00a0 TIME: 2:00 pm ET REGISTER HERE Available for 1&#215;1 meetings: June 24-25. Schedule 1&#215;1 Meetings here. The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference. It is recommended that online investors pre-register and run the online system check to expedite participation and receive &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-973255","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) &#8212; Aspire Biopharma Holdings, Inc.\u2019s (Nasdaq: ASBP) (\u201cAspire\u201d or the \u201cCompany\u201d), today announced that it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25th, 2026. DATE: June 25th\u00a0\u00a0 TIME: 2:00 pm ET REGISTER HERE Available for 1&#215;1 meetings: June 24-25. Schedule 1&#215;1 Meetings here. The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference. It is recommended that online investors pre-register and run the online system check to expedite participation and receive &hellip; Continue reading &quot;Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-17T15:00:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th\",\"datePublished\":\"2026-06-17T15:00:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/\"},\"wordCount\":404,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/\",\"name\":\"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=\",\"datePublished\":\"2026-06-17T15:00:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/","og_locale":"en_US","og_type":"article","og_title":"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th - Market Newsdesk","og_description":"ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) &#8212; Aspire Biopharma Holdings, Inc.\u2019s (Nasdaq: ASBP) (\u201cAspire\u201d or the \u201cCompany\u201d), today announced that it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25th, 2026. DATE: June 25th\u00a0\u00a0 TIME: 2:00 pm ET REGISTER HERE Available for 1&#215;1 meetings: June 24-25. Schedule 1&#215;1 Meetings here. The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference. It is recommended that online investors pre-register and run the online system check to expedite participation and receive &hellip; Continue reading \"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-17T15:00:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th","datePublished":"2026-06-17T15:00:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/"},"wordCount":404,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/","name":"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=","datePublished":"2026-06-17T15:00:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0ODU4MSM3NjY1NTQxIzIyMzMwNDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspire-biopharma-to-present-at-the-life-sciences-investor-forum-on-june-25th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/973255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=973255"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/973255\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=973255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=973255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=973255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}